Evolent Health (EVH) director receives 41,096 restricted stock units in equity grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Jelinek Richard M reported acquisition or exercise transactions in this Form 4 filing.
Evolent Health, Inc. director Richard M. Jelinek reported an equity award of Class A common stock. He received 41,096 restricted stock units at no purchase price under the company’s Amended and Restated 2015 Omnibus Incentive Compensation Plan. These units vest on the earlier of June 4, 2027, or the company’s 2027 annual meeting, if he continues serving through that date.
After the award, he holds 77,533 shares of Class A common stock directly, with additional 15,000-share positions shown in each of two trusts as indirect holdings.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Jelinek Richard M
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 41,096 | $0.00 | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Class A Common Stock — 77,533 shares (Direct, null);
Class A Common Stock — 15,000 shares (Indirect, By the Richard M Jelinek Revocable Trust)
Footnotes (1)
- Represents restricted stock units granted to Mr. Jelinek pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date.
Key Figures
RSU grant size: 41,096 shares
Grant price: $0.00 per share
Direct holdings after grant: 77,533 shares
+3 more
6 metrics
RSU grant size
41,096 shares
Restricted stock units of Class A Common Stock granted to Jelinek
Grant price
$0.00 per share
Price per share for the RSU award
Direct holdings after grant
77,533 shares
Class A Common Stock directly held by Jelinek post-transaction
GST trust holdings
15,000 shares
Class A Common Stock held by the Richard M. Jelinek GST
Revocable trust holdings
15,000 shares
Class A Common Stock held by the Richard M. Jelinek Revocable Trust
Vesting date
June 4, 2027
Latest vesting date for the 41,096 RSUs
Key Terms
restricted stock units, Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan, vesting, Class A Common Stock
4 terms
restricted stock units financial
"Represents restricted stock units granted to Mr. Jelinek pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan financial
"Represents restricted stock units granted to Mr. Jelinek pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan."
vesting financial
"Securities vest on the earlier of June 4, 2027, and the date of the Company's 2027 annual meeting, subject to the reporting person's continued service on the vesting date."
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Class A Common Stock financial
"security_title: Class A Common Stock"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
FAQ
What did Evolent Health (EVH) director Richard M. Jelinek report on this Form 4?
Richard M. Jelinek reported receiving 41,096 restricted stock units of Evolent Health Class A common stock. The award was made under the company’s Amended and Restated 2015 Omnibus Incentive Compensation Plan as part of his director compensation.
When do Richard M. Jelinek’s new Evolent Health (EVH) restricted stock units vest?
The 41,096 restricted stock units vest on the earlier of June 4, 2027, or the date of Evolent Health’s 2027 annual meeting, provided Jelinek continues to serve the company through the applicable vesting date.
What is the transaction price for Richard M. Jelinek’s new Evolent Health (EVH) stock units?
The 41,096 restricted stock units were granted at a price per share of $0.00. This indicates they are compensation awards rather than open-market purchases, consistent with typical equity grants to directors of public companies.
Under which plan were Richard M. Jelinek’s Evolent Health (EVH) restricted stock units granted?
The restricted stock units were granted under the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. This plan governs equity-based awards such as RSUs for directors, executives, and other eligible participants.